BioSpace News Archive

Erectile dysfunction is among the most commonly occurring sexual disorder. There are several reasons that may cause such disorder.

The global healthcare automation market is estimated to project a significant graph of growth in the forthcoming years.

The demand within the global biodegradable stents market is ascending at an exponential rate in recent times.

The denture disinfectants market survey offers insights into chief growth drivers and restrains impacting the overall growth trajectory.

Genespire, a next generation gene therapy company developing first-in-class transformative therapies with advanced lentiviral vectors, announces the appointment of Philippe Mauberna, as Chief Financial Officer, effective immediately.

Strongbridge Biopharma plc, today announced that post hoc analyses from a one year open-label study evaluating daily use of KEVEYIS®.

GenScript® , the world’s leading life science service provider, announced today the first GenScript Gene & Cell Engineering Virtual Summit.

Convergent Therapeutics today announced that Philip Kantoff , M.D., a world-renowned medical oncologist, former Chairman of the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK) and Co-Founder of Convergent, has been appointed as the company’s Chief Executive Officer, effective July 1, 2021.

Curia, formerly AMRI, today announced it has entered into a definitive agreement to acquire Integrity Bio, Inc., a privately held formulation and fill-finish organization headquartered in Camarillo, California.

Eargo, Inc. a medical device company on a mission to improve the quality of life for people with hearing loss through accessibility and affordability, is announcing the launch of Eargo 5, the company’s most advanced hearing aid to date, on Tuesday, July 13th.